General definitions of procedure indications from various specialty societies , including the ACA: * A screening colonoscopy is done to look for disease, such as cancer, and treat early conditions, if indicated, in people without symptoms. * A diagnostic colonoscopy is done to confirm or rule out a condition in a person who is symptomatic ...
Definition of Terms Colonoscopy: A colonoscopy is a procedure that permits the direct examination of the mucosa of the entire colon by using a flexible lighted tube. The procedure is done with sedation in a hospital outpatient department, in a clinic , or an office facility. During the colonoscopy a doctor can biopsy and remove pre – cancerous ...
A provider also can be a place where medical care is given, like a hospital, clinic, or lab.This policy informs them about when a service may be covered.
This guideline applies only to people of average risk. Colonoscopy is only one of the screening tests that can be used. This benefit coverage guideline provides general information about how the health plan decides whether a colonoscopy is covered under the preventive or diagnostic (medical) benefits.
CPT codes, descriptions and other data only are copyright 2020 American Medical Association. All Rights Reserved. Applicable FARS/HHSARS apply.
Abstract:#N#This article represents local instructions for CMS National Coverage Policy (CMS Publication 100-03, Medicare National Coverage Determinations (NCD) Manual, Chapter 1, Section 210.3).
Contractors may specify Bill Types to help providers identify those Bill Types typically used to report this service. Absence of a Bill Type does not guarantee that the article does not apply to that Bill Type.
Contractors may specify Revenue Codes to help providers identify those Revenue Codes typically used to report this service. In most instances Revenue Codes are purely advisory. Unless specified in the article, services reported under other Revenue Codes are equally subject to this coverage determination.
Oncology (colorectal) screening, quantitative real-time target and signal amplification of 10 DNA markers (KRAS mutations, promoter methylation of NDRG4 and BMP3) and fecal hemoglobin, utilizing stool, algorithm reported as a positive or negative result
For multi-target stool DNA (sDNA) test, use Z12.11 Encounter for screening for malignant neoplasm of colon and Z12.12 Encounter for screening for malignant neoplasm of rectum.
For colorectal cancer screening using multitarget sDNA test, coverage applies to all Medicare patients who fall are:
For patients not meeting criteria for high risk, frequency limitations are:
For 81528, 82270, G0104, G0105, G0121, and G0328, the following is waived:
Preventive Services Task Force (USPSTF):#N#A screening colonoscopy is performed once every 10 years for asymptomatic patients aged 50-75 with no history of colon cancer, polyps, and/or gastrointestinal disease.#N#A surveillance colonoscopy can be performed at varying ages and intervals based on the patient’s personal history of colon cancer, polyps, and/or gastrointestinal disease. Patients with a history of colon polyp (s) are not recommended for a screening colonoscopy, but for a surveillance colonoscopy. Per the USPSTF, “When the screening test results in the diagnosis of clinically significant colorectal adenomas or cancer, the patient will be followed by a surveillance regimen and recommendations for screening are no longer applicable.”#N#The USPSTF does not recommend a particular surveillance regime for patients who have a personal history of polyps and/or cancer; however, surveillance colonoscopies generally are performed in shortened intervals of two to five years. Medical societies, such as the American Society of Colon and Rectal Surgeons and the American Society of Gastrointestinal Endoscopy, regularly publish recommendations for colonoscopy surveillance.#N#The type of colonoscopy will fall into one of three categories, depending on why the patient is undergoing the procedure.#N#Diagnostic/Therapeutic colonoscopy (CPT® 45378 Colonoscopy, flexible, proximal to splenic flexure; diagnostic, with or without collection of specimen (s) by brushing or washing, with or without colon decompression (separate procedure))#N#Patient has a gastrointestinal sign, symptom (s), and/or diagnosis.#N#Preventive colonoscopy screening (CPT® 45378, G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk)#N#Patient is 50 years of age or older#N#Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis#N#Patient does not have any personal history of colon cancer, polyps, and/or gastrointestinal disease#N#Patient may have a family history of gastrointestinal sign, symptom (s), and/or relevant diagnosis#N#Exception: Medicare patients with a family history (first degree relative with colorectal and/or adenomatous cancer) may qualify as “high risk.” Colonoscopy for these patients would not be a “surveillance,” but a screening, reported with HCPCS Level II code G0105 Colorectal cancer screening; colonoscopy on individual at high risk.#N#Surveillance colonoscopy (CPT® 45378, G0105)#N#Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis.#N#Patient has a personal history of colon cancer, polyps, and/or gastrointestinal disease.
According to ICD-9-CM Official Guidelines for Coding and Reporting, section 18.d.4:#N#There are two types of history V codes, personal and family . Personal history codes explain a patient’s past medical condition that no longer exists and is not receiving any treatment, but that has the potential for recurrence, and therefore may require continued monitoring. Personal history codes may be used in conjunction with follow-up codes and family history codes may be used in conjunction with screening codes to explain the need for a test or procedure.#N#Common personal history codes used with colonoscopy are V12.72 and V10.0x Personal history of malignant neoplasm of the gastrointestinal tract. The family history codes include V16.0 Family history of malignant neoplasm of the gastrointestinal tract; V18.51 Family history of colonic polyps; and V18.59 Family history of other digestive disorders. Lastly, V76.51 describes screening of the colon.#N#Per the ICD-9-CM official guidelines, you would be able to report V76.51 (screening) primary to V16.0 (family history of colon polyps). In contrast, you would not use V76.51 (screening) with V12.72 (personal history of colon polyps) because family history codes, not personal history codes, should be paired with screening codes. Personal history would be paired with a follow-up code.#N#Just because you get paid doesn’t mean the coding is correct: Most carriers will pay V76.51 with V12.72 because their edits are flawed and allow it. The patient’s claim will process under a patient’s preventative benefits with no out-of-pocket; however, an audit of the record with the carrier guidance will reveal that the claim incorrectly paid under preventative services when, in fact, the procedure should have paid as surveillance. The best strategy is to contact your payer to be sure you are coding correctly based on that payer’s “screening vs. surveillance” guidelines.
Anna Barnes, CPC, CEMC, CGSCS, is the director of operations for Atlanta Colon and Rectal Surgery.
Colonoscopy for these patients would not be a “ surveillance,” but a screening, reported with HCPCS Level II code G0105 Colorectal cancer screening; colonoscopy on individual at high risk. Patient does not have any gastrointestinal sign, symptom (s), and/or relevant diagnosis.